High-dose interleukin-2
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for High-dose interleukin-2, covering 2016-04-26 to 2020-02-19. Get the full timeline:
Most recent: Clinical Trial Update: High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI [Phase 2]